Indian box office surpassed “Venom: The Last Dance” and “Joker 2” to win the best premiere of the trilogy

October 26, 2024: Venom: The Last DanceThe final film in Tom Hardy’s popular superhero trilogy debuted well at the Indian box office, exceeding expectations. Despite mixed reviews, the film’s box office performance was better than or even better than its predecessor Joker 2 Day one. Here’s how the movie fared on its opening day.

Directed by Kelly Marcel, Venom: The Last Dance Released on October 24, 2024. The film generated quite a bit of hype upon its release Venom: Carnage Despite its poor performance at the Indian box office in 2021, it still generated a huge response. Fans have high hopes for the third installment’s redemption arc, and early data suggests the film may be a success.

Also read: This week, cinemas offer new movies, classic re-releases and a feast of horror

Venom 3 box office revenue (India) Venom: The Last Dance It earned Rs 550 crore on its first day of operation in India. It’s a good start considering it’s a normal working day, and industry insiders are optimistic that attendance at evening and night screenings of the film will increase as the weekend approaches, setting up for a strong showing on Friday. Be prepared.

Also read: Patti Review: Kajol, Kriti Sanon Starrel fail to impress due to weak plot and muddled execution

interestingly, venom 3 Out by a slim margin Joker 2The film starring Joaquin Phoenix and Lady Gaga grossed Rs 510 crore on its first day in India.

Better than previous installments Venom: The Last Dance It also surpassed its predecessor in terms of opening day collection, making it the best debut in the trilogy. Here’s a comparison of the three movies:

1. Venom (2018): 40.9 Crores Rs.
2. Venom: Carnage (2021): 371 Crores Rs.
3. Venom: The Last Dance (2024): 550 Crores Rs.

more about Venom: The Last Dance The film boasts a stellar supporting cast, including Chiwetel Ejiofor, Juno Temple, Rhys Ifans, Stephen Graham, Peggy Lou, Clark Bacow and Alanna Ubach. As the fifth installment in Sony’s Spider-Man universe, the film continues to explore the complex relationship between Eddie Brock and the symbiote Venom.

While Tom Hardy and his co-stars were praised for their performances, the film was criticized for its weak script. It remains to be seen whether the film can maintain its momentum over the weekend, but for now, it’s off to a positive start in India.